Changes in the cardiac β-adrenergic system provoked by different T. cruzi strains

International Journal of Cardiology

Volumn 111, Issue 1, 2006, Pages 104-112

  Lo Presti, M Silvina ^a   Bustamante, Juan Manuel ^a   Rivarola, Walter H ^a   Fernández, Alicia R ^a,b   Enders, Julio E ^a   Fretes, Ricardo ^a   Levin, Gloria ^c   Paglini Oliva, Patricia A ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^c HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

Author keywords

Acute Chagas' disease; Cardiac contractility; Myocardiopathy; Physiopathology; Trypanosoma cruzi strains; Adrenergic signal transduction system

Indexed keywords

BETA ADRENERGIC RECEPTOR; CATECHOLAMINE; CYCLIC AMP;

ADRENERGIC SYSTEM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; ENDEMIC DISEASE; HEART FUNCTION; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TRYPANOSOMA CRUZI;

EID: 33746311796     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.07.032     Document Type: Article

References (57)

1. World Health Organization. Chagas disease: tropical disease progress in research, 1997-1998. WHO Tech. Rep. Ser. vol. 1 (1999) 1
2. Brodde O.E. β-Adrenergic receptor in failing human myocardium. Basic Res. Cardiol. 91 (1996) 35-40
3. Hoffman B.B., and Lefkowitz R.J. In: Hardman J.G., Gilman A.G., and Limbird L.E. (Eds). Goodman and Gilman's the pharmacological basis of therapeutics (1996), McGraw-Hill, New York 199-248
4. Dzimiri N. Regulation of β-adrenoceptor signalling in cardiac function and disease. Pharmacol Rev 51 3 (1999) 465-501
5. Movsesian M. Altered cAMP-mediated signalling and its role in the pathogenesis of dilated cardiomyopathy. Cardiovasc Res 62 3 (2004) 450-459
6. Enders J.E., Paglini P., Fernández A.R., Marco F., and Palma J.A. Cardiac β receptor in experimental Chagas disease. Rev Inst Med Trop Sao Paulo 37 (1995) 59-62
7. Fernández A.R., Enders J.E., Rivarola W.H., Paglini P., and Palma J.A. Cardiac β receptors' density or affinity modified by different Trypanosoma cruzi amount. Acta Physiol Phamacol Ther Lat 47 (1996) 137-143
8. Enders J.E., Fernández A.R., Rivarola H.W., Paglini P.A., and Palma J.A. Studies of membrane fluidity and heart contractile force in Trypanosoma cruzi infected mice. Mem Inst Oswaldo Cruz 99 7 (2004) 691-696
9. Gilman A.G. G proteins: transducers of receptor generated signals. Annu Rev Biochem 57 (1987) 615-649
10. Gilman A. Regulations of adenylyl cyclase by G proteins. In: Nishizuka Y. (Ed). The biology and medicine of signal transduction (1990), Raven Press, New York 51-57
11. Kamp T.J., and Hell J.W. Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C. Circ Res 87 (2000) 1095-1102
12. 16) phosphorylation in phospholamban is sufficient in mediating its maximal cardiac responses to β agonists. J Biol Chem 275 49 (2000) 38938-38943
13. Chu G., and Kranias E.G. Functional interplay between dual site phospholamban phosphorylation: insights from genetically altered mouse models. Basic Res Cardiol 97 Suppl. 1 (2002) 143-148
14. Hagemann D., and Xiao R.P. Dual site phospholamban phosphorylation and its physiological relevance in the heart. TCM 12 2 (2002) 51-56
15. Pickett-Gies C.A., and Walsh D.A. Subunit phosphorylation and activation of skeletal muscle phosphorylase kinase by the cAMP-dependent protein kinase. J Biol Chem 260 4 (1985) 2046-2056
16. Brushia R.J., and Walsh D.A. Phosphorylase kinase: the complexity of its regulation is reflected in the complexity of its structure. Front Biosci 4 (1999) D618-D641
17. Perry S.V. Troponin I: inhibitor or facilitator. Mol Cell Biochem 190 (1999) 9-32
18. Peña R.P., and Wolska B.M. Troponin I phosphorylation plays an important role in the relaxant effect of β-adrenergic stimulation in mouse hearts. Cardiovasc Res 61 (2004) 756-763
19. Mayr B., and Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2 (2001) 599-609
20. Wu G., Deisseroth K., and Tsien R.W. Activity-dependent CREB phosphorylation: Convergence of a fast, sensitive calmodulin kinase pathway and a slow, less sensitive mitogen-activated protein kinase pathway. Proc Natl Acad Sci 98 5 (2001) 2808-2813
21. Esposito G., Rapacciuolo A., Naga Prasad A.V., and Rockman H.A. Cardiac hypertrophy: role of G protein-coupled receptors. J Card Fail 8 6 (2002) S409-S414
22. Borda E.S., and Sterin-Borda L. Antiadrenergic and muscarinic receptor antibodies in Chagas's cardiomyopathy. Int J Cardiol 54 (1996) 149-156
23. Sterin-Borda L., Gorelik G., Postan M., Gonzalez Cappa S., and Borda E. Alterations in cardiac beta-adrenergic receptors in chagasic mice and their association with circulating beta-adrenoceptor-related autoantibodies. Cardiovasc Res 41 (1999) 116-125
24. Goin J.C., Perez Leiros C., Borda E.S., and Sterin-Borda L. Interaction of human chagasic IgG with the second extracellular loop of the human heart muscarinic acetylcholine receptor: functional and pathological implications. FASEB J 11 (1997) 77-83
25. Macedo A.M., and Pena S.D.J. Genetic variability of Trypanosoma cruzi: implications for the Pathogenesis of Chagas Disease. Parasitol Today 14 (1998) 119-124
26. Machado C.A., and Ayala F.J. Nucleotide sequences provide evidence of genetic exchange among distantly related lineages of Trypanosoma cruzi. Proc Natl Acad Sci 98 13 (2001) 7396-7401
27. Murta S.M.F., and Romanha A.J. Characterization of Trypanosoma cruzi. Mem Inst Oswaldo Cruz 94 1 (1999) 177-180
28. Revollo S., Oury B., and Laurent J.P. Trypanosoma cruzi: impact of clonal evolution of the parasite on its biological and medical properties. Exp Parasitol 89 (1998) 30-39
29. Andrade S.G. Trypanosoma cruzi: clonal structure of parasite strains and the importance of principal clones. Mem Inst Oswaldo Cuz 94 (1999) 185-187
30. Taliaferro W.H., and Pizzi T. Connective tissue reactions in normal and immunized mice to a reticulotropic strain of Trypanosoma cruzi. J Infect Dis 96 (1955) 199-226
31. Montamat E.E., De Luca D'Oro G.M., Galerano R.H., Sosa R., and Blanco A. Characterization of Trypanosoma cruzi population by zymodemes: correlation with clinical picture. Am J Trop Med Hyg 55 (1996) 625-628
32. Bustamante J.M., Rivarola H.W., Fernández A.R., et al. Trypanosoma cruzi reinfections provoke synergistic effect and cardiac β-adrenergic receptors' dysfunction in the acute phase of experimental Chagas' disease. Exp Parasitol 103 (2003) 136-142
33. Paglini-Oliva P., Fernández A.R., and Lacuara J.L. Pharmacological and Contractile Response of Myocardium of Chagasic Albino Swiss Mice. Acta Phys Pharm Lat Am 37 (1987) 395-401
34. Eisenhofer G., Goldstein D.S., Stull R., et al. Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin Chem 32 (1986) 2030-2033
35. Bohm M., Flesch M., and Scgnabel P. Role of G-proteins in altered β-adrenergic responsiveness in the failing and hypertrophied myocardium. Basic Res Cardiol 91 Suppl. 2 (1996) 47-51
36. Chakraborti S., Chakraborti T., and Shaw G. β-Adrenergic mechanisms in cardiac diseases. A perspective. Cell Signal 12 (2000) 499-513
37. Rockman H.A. Uncoupling of G-protein coupled receptors in vivo: insights from transgenic mice. Adv Exp Med Biol 430 (1997) 67-72
38. White M., Wiechmann R.J., Roden R.L., et al. Cardiac β-adrenergic neuroeffector systems in acute myocardial dysfunction related to brain injury. Evidence for catecholamine-mediated myocardial damage. Circulation 92 8 (1995) 2183-2189
39. Mills S.E. Implications of feedback regulation of beta-adrenergic signalling. J Anim Sci 80 E Suppl. 1 (2002) E30-E35
40. Ungerer M., Bohm M., Elce J.S., Erdmann E., and Lohse M.J. Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. Circulation 87 2 (1993) 454-463
41. Iaccarino G., Tomhave E.D., Lefkowitz R.J., and Koch W.J. Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by β-adrenergic receptor stimulation and blockade. Circulation 98 17 (1998) 1783-1789
42. Freedman N.J., and Lefkowitz R.J. Desensitization of G protein-coupled receptors. Recent Prog Horm Res 51 (1996) 319-351 (discussion 352-3)
43. Goin J.C., Borda E., Segovia A., and Sterin-Borda L. Distribution of antibodies against β-adrenoceptors in the course of human Trypanosoma cruzi infection. Proc Soc Exp Biol Med 197 (1991) 186-192
44. Goin J.C., Perez-Leiros C., Borda E., and Sterin-Borda L. Human chagasic IgG and muscarinic cholinergic receptor interaction: pharmacological and molecular evidence. Mol Neuropharmacol 3 (1994) 186-196
45. Elies R., Ferrari I., Wallukat G., et al. Structural and functional analysis of the B cell epitopes recognized by anti-receptor autoantibodies in patients with Chagas disease. J Immunol 157 (1996) 4203-4211
46. Kierszenbaum F. Chagas disease and the autoimmunity hypothesis. Clin Microb Rev 12 2 (1999) 210-223
47. Kierszenbaum F. Views on the autoimmunity hypothesis for Chagas disease pathogenesis. FEMS Immunol Med Microb 37 (2003) 1-11
48. 4-receptor-deficient mice. Br J Pharmacol 138 3 (2003) 469-480
49. Storino R., and Milei J. Enfermedad de Chagas (1994), Mosby/Doyma Argentina, Buenos Aires
50. Kadambi V.J., and Kranias E.G. Phospholamban: a protein coming of age. Biochem Biophys Res Commun 239 1 (1997) 1-5
51. Simmerman H.K., and Jones L.R. Phospholamban: protein structure, mechanism of action, and role in cardiac function. Physiol Rev 78 4 (1998) 921-947
52. Fernández-Culasso A., Paglini-Oliva P., Palma J.A., and Lacuara J.L. Isometric developed tension and histopathology of myocardium of chagasic mice. Acta Physiol Pharmacol Ther Latinoam 41 4 (1991) 397-404
53. 1-adrenergic receptor and modifies myocardial contractile activity. Mol Biochem Parasitol 127 (2003) 169-177
54. Tibbetts R.S., Mc Cornick E.C., Rowland S.D., and Enzman D.M. Cardiac antigen-specific autoantibody production in associated with cardiomyopathy in T. cruzi-infected mice. J Immunol 152 (1994) 1493-1498
55. Gironès N., and Fresno M. Etiology of Chagas disease myocarditis: autoimmunity, parasite persistence, or both?. Trends Parasitol 19 1 (2003) 19-22
56. Neumann J., Eschenhagen T., Jones L.R., et al. Increased expression of cardiac phosphatases in patients with end-stage hearts failure. J Mol Cell Cardiol 29 (1997) 265-272
57. Carr A.N., Schmidt A.G., and Suzuki Y. Type 1 phosphatase, a negative regulator of cardiac function. Mol Cell Biol 22 12 (2002) 4124-4135